Mankind Pharma
MANKIND · Pharma > Pharmaceuticals & Drugs Listing date: May 9, 2023

Stock Price vs Company Growth
1d
1.5%
1w
0.4%
1m
2.2%
3m
4.2%
6m
21.6%
1y
1.7%
all
17.2%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 2,440 1.5%
2,221
2,640
Company Overview

Sales
14,738 Cr
Growth: 14.2%
Profit after Tax
2,043 Cr
Growth: 6.8%
Large Cap
1,00,764 Cr
P/E: 49.4x
Industry P/E: 35.1x
Fundamentals

Sales (Cr) ₹ 14,738
Growth 14.2%
EBITDA 26.0%
P/S 6.8x
Dividend 0.0%
P/E 49.4x
Book Value ₹ 408
PEG Ratio 3.5x
ROE 12.7%
P/B 6.0x
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

The company is India’s one of the leading pharmaceutical company with a diversified portfolio - from pharma and super specialty to consumer healthcare backed by strong in-house R&D capabilities with an established and deeply penetrated presence across India. The company is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products.
Investors (1)
Followers (2)